CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the Ileum in Crohn's disease

Connor, S. J.; Paraskevopoulos, N.; Newman, R.; Cuan, N.; Hampartzoumian, T.; Lloyd, A. R.; Grimm, M. C.
September 2004
Gut;Sep2004, Vol. 53 Issue 9, p1287
Academic Journal
Background and aims: Chemokine receptors are key determinants of leucocyte trafficking. While the chemokine receptor CCR9 and its chemokine ligand CCL25 (TECK) mediate lymphocyte homing to the healthy small intestine, the chemokine receptors important for recruitment during intestinal inflammation are undefined. Animal studies have suggested potential roles for CCR2 and CCR5 in inflammatory bowel disease (IBD). The aim of this study was to understand the role of CCR2 in human IBD. Methods: Resections of ileum or colon were obtained from patients undergoing surgery for small bowel Crohn's disease (SBCD; n = 10), Crohn's colitis (n = 5), ulcerative colitis (n = 6), and non-IBD related conditions (control ileum n = 11; control colon n = 11). Expression of CCR2 by lamina propria lymphocytes (LPLs) was determined by both flow cytometry and immunohistochemistry. As a functional correlate, chemotaxis assays using the CCR2 ligand, CCL2 (MCP-1), were performed. Expression of CCR2 by peripheral blood lymphocytes was determined by flow cytometry. Results: There were greater than 30-fold more CCR2+ LPLs in SBCD than in control ileum (29.3% (19.9-55.1) v 0.9% (0.4-11.5); p = 0.0007). Specifically, CCR2+CD4+ LPLs were increased (p = 0.002) whereas CCR2+CD8+ LPLs were not. Increased expression included both memory (CD45RO+; p = 0.005) and naive (CD45RO(-); p = 0.01) CCR2+ populations. The increase in CCR2+ LPLs in SBCD was confirmed by both immunohistochemistry (p = 0.0002) and enhanced chemotactic responses to CCL2. CCR2 expression was not increased in the peripheral blood of patients with SBCD, suggesting ongoing recruitment of the CCR2+ population to the ileum. In contrast with SBCD, there was no significant increase in CCR2+ LPLs in Crohn's colitis or ulcerative colitis samples. Conclusions: The chemokine receptor CCR2 appears to be an important contributor to accumulation of CD4+ T lymphocytes in the ileum in small bowel Crohn's disease. Blockade of CCR2 may provide a novel therapeutic alternative.


Related Articles

  • REGIONAL ENTERITIS. Berger, Samuel S. // American Journal of Gastroenterology;Jul1956, Vol. 26 Issue 1, p81 

    Presents a case of a patient with regional enteritis. Persistence of abdominal pains suffered by the patient; Examination of the abdomen of the patient; Pathology of the regional enteritis.

  • Granulomatous Enterocolitis Complicated by Osteomyelitis. Meltzer, Saul S. // American Journal of Gastroenterology;Jan1973, Vol. 59 Issue 1, p77 

    Osteomyelitis complicating granulomatous disease of the bowel is described in a case report. Bony complications of this disorder should be kept in mind since they may occur more commonly than has previously been appreciated.

  • Endoscopic Management of Inflammatory Bowel Disease. Modigliani, Robert // American Journal of Gastroenterology;Aug1994 Supplement, Vol. 89 Issue 8, pS53 

    Discusses the role of endoscopy in inflammatory bowel disease. Discussion on the basic endoscopic lesions on inflammatory bowel disease; Definition of the nature of stricture and mass lesions; Evaluation of patients with cholestasis; Analysis of endoscopic treatment of intestinal strictures in...

  • NOD takes its toll but stays in the CARDs in Crohn’s disease. Luft, Friedrich // Journal of Molecular Medicine;Aug2005, Vol. 83 Issue 8, p577 

    Points out to the growing body of evidence implicating nucleotide-binding oligomerization domain (NOD) 2 and toll-like receptor (TLR) 4 mutations in Crohn's disease. Occurrence of inflammatory bowel diseases in areas of the gastrointestinal tract with the highest numbers of luminal bacteria;...

  • Advances in the Inflammatory Bowel Diseases.  // Gut;Jul2004, Vol. 53 Issue 7, p1058 

    The article presents that the conference for advances in the inflammatory bowel diseases will be held in Chicago, Illinois, from October 8-9, 2004.

  • Vitamin Status in Patients with Inflammatory Bowel Disease. Fernandez-Banares, F.; Abad-Lacruz, A.; Xiol, X.; Gine, J. J.; Dolz, C.; Cabre, E.; Esteve, M.; Gonzalez-Huix, F.; Gassull, M. A. // American Journal of Gastroenterology;Jul1989, Vol. 84 Issue 7, p744 

    The status of water- and fat-soluble vitamins was prospectively evaluated in 23 patients (13 men, 10 women, mean age 33 ± 3 yr) admitted to the hospital with acute or subacute attacks of inflammatory bowel disease. Protein-energy status was also assessed by means of simultaneous measurement...

  • THE DIAGNOSIS AND TREATMENT OF CHRONIC REGIONAL ENTERITIS. Shaiken, Joseph // American Journal of Gastroenterology;Nov1957, Vol. 28 Issue 5, p566 

    Discusses the diagnosis and treatment of chronic regional enteritis. Components of abdominal mass; Changes in the small intestine that aid diagnosis; Elements of medical treatment.

  • Cryptogenic multifocal ulcerous stenosing enteritis. Spencer, Hal; Kitsanta, Panagiota; Riley, Stuart // Journal of the Royal Society of Medicine;Nov2004, Vol. 97 Issue 11, p538 

    The article presents a case of woman who suffered colicky lower abdominal pain, iron deficiency anemia, and mild chronic obstructive pulmonary disease. During her laparotomy, two strictures were detected in the proximal ileum and was associated to that of cryptogenic multifocal ulcerous...

  • A Double-Blind Clinical Trial for Treatment of Crohn's Disease by Oral Administration of Alequelâ„¢, A Mixture of Autologous Colon-Extracted Proteins: A Patient-Tailored Approach. Margalit, Maya; Israeli, Eran; Shibolet, Oren; Zigmond, Ehud; Klein, Athalia; Hemed, Nilla; Donegan, James J.; Rabbani, Elazar; Goldin, Eran; Ilan, Yaron // American Journal of Gastroenterology;Mar2006, Vol. 101 Issue 3, p561 

    OBJECTIVES: In this study, we evaluated the safety and efficacy of a personalized mode of treatment for Crohn's disease (CD) by oral administration of Alequelâ„¢, an extract of autologous colonic proteins. METHODS: Thirty-one patients with moderate to severe CD were enrolled in a 27-wk...


Read the Article


Sign out of this library

Other Topics